Azithromycin can become deficient
For the treatment of coronavirus infection doctors around the world use a variety of drugs outside of approved indications. In one of the experimental regimens COVID-19 was included the antibiotic azithromycin, although evidence of its effectiveness, writes FierceBiotech. High demand for the drug can lead to its deficit, said the producers.
The largest manufacturers of azithromycin are Teva and Pfizer, they warned about possible delays in the supply despite increasing production.
Azithromycin FDA already included in the list of scarce drugs.
